CEBPA double-degree gene mutation is a dubious disease in the field of blood tumors, with complex clinical outcomes and often involving multi-system congestion. Early identification and standardized diagnosis are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical outcomes, imaging checks, laboratory checks and pathological checks.
The platform can help align teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of acute myelogenous leukemia-associated CBBPA double-spectrum gene mutations require individualized development, typically including multidimensional management of drug therapy, rehabilitation interventions, regular follow-up, etc. In recent years, with the development of targeted therapy, immune-regulated therapy, and precision medicine, significant improvements have been made in many previously difficult-to-treat blood tumour diseases.
Therapeutic and adverse reactions need to be closely monitored throughout the treatment process, and timely adjusted according to changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the overall management of CBBPA double-spectrum gene mutations associated with acute myelogenous leukemia. The platform serves the China International Medical Service System, which combines a team of authoritative experts at home and abroad in the field of blood oncology, to provide the following services to patients: 1.
Remote pre-diagnosis: pre-examination of medical history, precise diagnostic directions and medical advice by a team of experts; 2. Interviews in China: arranging face-to-face diagnosis with authoritative experts, developing personalized treatment programs; 3. Full-service: providing one-stop services: providing medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects. Support for remote pre-diagnosis, visiting interviews, full translation and escort.